natgillin/translations-raw huggingface dataset:
If any of the above conditions change while you are using IOA, for example, you start smoking, a close family member experiences a thrombosis for no known reason or you gain a lot of weight, tell 
Zdravniku morate povedati, če se kaj od naštetega med vašo uporabo zdravila IOA spremeni, na primer če začnete kaditi, če se kakšnemu bližnjemu sorodniku pojavi tromboza brez znanega razloga, ali če se močno zredite.
If a woman has more than one risk factor, it is possible that the increase in risk is greater than the sum of the individual factors - in this case her total risk of VTE should be considered. 
je lahko povečanje tveganja večje od seštevka posameznih dejavnikov - v takšnem primeru je treba upoštevati njeno celotno tveganje za VTE.
Positive family history (arterial thromboembolism ever in a sibling or parent especially at relatively 
Pozitivna družinska anamneza (arterijska trombembolija pri sorojencu ali staršu, zlasti v sorazmerno zgodnji starosti, npr. pred 50. letom)
• Known or suspected sex steroid-influenced malignancies (e.g., of the genital organs or the 
• Znane maligne bolezni ali sum nanje (npr. genitalnih organov ali dojk), zaradi vpliva steroidnih spolnih hormonov.
But if you are having intercourse, make sure you also use a barrier method of contraception for the first 7 days that you are taking IOA. 
Če pa imate spolne odnose, morate prvih 7 dni jemanja zdravila IOA uporabljati tudi pregradno metodo kontracepcije.
No clinically relevant effect of food was observed on the bioavailability 
Opazili niso nobenega klinično pomembnega vpliva hrane na biološko uporabnost estradiola.
IOA is not indicated during pregnancy. 
Nosečnost Zdravilo IOA ni indicirano za uporabo med nosečnostjo.
• swelling of one leg or along a vein in the leg or foot especially when • pain or tenderness in the leg which may be felt only when 
• oteklost ene noge ali vzdolž vene v nogi ali stopalu, zlasti če jo spremlja:
At the end of the placebo tablet interval, start with the next blister. 
Ko zaključite z jemanjem placebo tablet, začnite z jemanjem tablet iz naslednjega pretisnega omota.
Reproductive toxicity studies performed with the combination have shown foetotoxicity which is 
Študije vpliva na sposobnost razmnoževanja, opravljene s kombinacijo obeh učinkovin, so pokazale fetotoksičnost, ki je ustrezala stopnji izpostavljenosti estradiolu.
• In rare cases, benign liver tumours, and even more rarely, malignant liver tumours have been reported in users of COCs. 
• V redkih primerih so pri uporabnicah KPK poročali o nastanku benignih jetrnih tumorjev, še redkeje pa o malignih jetrnih tumorjih.
IOA 2.5 mg/1.5 mg film-coated tablets Nomegestrol acetate/estradiol 
IOA 2,5 mg/1,5 mg filmsko obložene tablete nomegestrolacetat/estradiol
When changing from another combined hormonal contraceptive (combined pill, vaginal ring, or 
Prehod z drugega kombiniranega hormonskega kontraceptiva (kombiniranih kontracepcijskih tabletk,
The 4 placebo tablets from the last row must be discarded. 
Vzeti mora placebo tablete iz zadnje vrste.
Stop taking the white active tablet immediately and go directly to the yellow placebo tablet interval. 
Takoj prenehajte z jemanjem belih aktivnih tablet in začnite z jemanjem rumenih placebo tablet.
Maximum plasma concentrations of nomegestrol acetate of about 7 ng/ml are reached at 2 h after single administration. 
Največjo plazemsko koncentracijo približno 7 ng/ml doseže nomegestrolacetat 2 h po enkratnem odmerku.
If she is more than 12 hours late in taking any active tablet, contraceptive protection may be reduced. 
Če pa z jemanjem katere koli tablete z zdravilno učinkovino zamuja več kot 12 ur, je kontracepcijska zaščita lahko zmanjšana.
However, use a barrier method as an extra precaution for the next 7 days. 
Naslednjih 7 dni uporabljajte pregradno metodo.
• if you know you have a disorder affecting your blood clotting - for instance, protein C deficiency, protein S deficiency, antithrombin - III deficiency, Factor V Leiden or 
• če veste, da imate motnjo, ki poslabša strjevanje krvi - na primer pomanjkanje proteina C,
Lactose monohydrate (see section 2 ‘IOA contains lactose'), cellulose microcrystalline (E460), crospovidone (E1201), talc (E553b), magnesium stearate (E572) and silica colloidal anhydrous Tablet coating (white active film-coated tablets): 
Jedro tablete (bele aktivne filmsko obložene tablete in rumene placebo filmsko obložene tablete): laktoza monohidrat (glejte poglavje 2 "Zdravilo IOA vsebuje laktozo"), mikrokristalna celuloza (E460), krospovidon (E1201), smukec (E553b), magnezijev stearat (E572) in brezvodni koloidni silikagel
If you have taken IOA every day according to these directions, it is unlikely that you are pregnant (see also section 3 ‘If you have missed one or more periods'). 
Upoštevajte, da nekatere uporabnice teh tablet nimajo menstruacije vsak mesec v času jemanja rumenih tablet in če ste zdravilo IOA jemali vsak dan v skladu s temi navodili, je zelo malo verjetno, da ste noseči (glejte tudi poglavje 3 "Če niste dobili ene ali več menstruacij").
- HIV infections (e.g. ritonavir, nevirapine, nelfinavir, efavirenz); - other infectious diseases (e.g. griseofulvin); - high blood pressure in the blood vessels in the lungs (bosentan). 
felbamat); - tuberkuloze (npr. rifampicin); - okužbe z virusom HIV (npr. ritonavir, nevirapin, nelfinavir, evafirenz); - drugih infekcijskih bolezni (npr. grizeofulvin)
• if you have (or have ever had) a blood clot in a blood vessel of your legs (deep vein thrombosis, DVT), your lungs (pulmonary embolus, PE) or other organs; 
• če imate (ali ste kdaj imeli) krvni strdek v žili v nogah (globoko vensko trombozo, DVT),
It is important to draw a woman's attention to the information on venous and arterial thrombosis, including the risk of IOA compared with other CHCs, the symptoms of VTE and ATE, the known risk factors and what to do in the event of a suspected thrombosis. 
IOA v primerjavi z drugimi CHC, s simptomi VTE in ATE, znanimi dejavniki tveganja in z ukrepanjem v primeru suma na trombozo.
You can stop taking IOA at any time. 
Če prenehate z jemanjem zdravila IOA Zdravilo IOA lahko prenehate jemati kadarkoli.
In the clinical trial performed with IOA in the European Union the following Pearl Indices for the age 
V kliničnem preskušanju, opravljenem z zdravilom IOA v Evropski uniji, so izračunali naslednje
Symptoms of a myocardial infarction (MI) can include: - pain, discomfort, pressure, heaviness, sensation of squeezing or fullness in the chest, arm, or below the breastbone; - discomfort radiating to the back, jaw, throat, arm, stomach; - feeling of being full, having indigestion or choking; 
- bolečina, nelagodje, tiščanje, teža, občutek stiskanja ali polnosti v prsih, roki ali za prsnico, - nelagodje, ki se širi v hrbet, čeljust, žrelo, roko ali proti želodcu, - občutek polnosti, prebavne motnje ali dušenje,
IOA contains lactose. 
Zdravilo IOA vsebuje laktozo.
If any of the above conditions change while you are using IOA, for example a close family member experiences a thrombosis for no known reason or you gain a lot of weight, tell your doctor. 
Zdravniku morate povedati, če se kaj od naštetega med vašo uporabo zdravila IOA spremeni, na primer, če se kakšnemu bližnjemu sorodniku pojavi tromboza brez znanega razloga, ali če se močno zredite.
However, the missed tablets should be discarded to avoid unintentionally prolonging the 
Te pozabljene placebo tablete mora zavreči, da ne bi kdaj pozneje nenamerno podaljšala faze jemanja placebo tablet.
If you get pregnant while using IOA you should stop using IOA and contact your doctor. 
Če zanosite med jemanjem zdravila IOA, ga prenehajte jemati in se posvetujte z zdravnikom.
For example, it can cause a heart attack or a stroke. 
srčni infarkt ali možgansko kap.
In addition to the above mentioned adverse reactions, hypersensitivity reactions have been reported in 
Poleg zgoraj navedenih neželenih učinkov so pri uporabnicah zdravila IOA poročali tudi o preobčutljivostnih reakcijah (neznana pogostnost).
It is unknown if this finding is due to the use of hormonal contraceptives or to other factors, such as difference in sexual behaviour. 
Zanj so poročali, da se pogosteje pojavlja pri ženskah, ki dlje časa jemljejo kontracepcijske tablete, ni pa znano, ali je ta ugotovitev posledica jemanja hormonskih kontraceptivov ali drugih dejavnikov, na primer razlik v spolnem vedenju.
The woman should start with IOA preferably on the day after the last active tablet (the last tablet containing the active substances) of her previous COC, but at the latest on the day following the usual tablet-free or placebo tablet interval of her previous COC. 
Prehod z drugega kombiniranega hormonskega kontraceptiva (kombinirane peroralne kontracepcijske tablete (KPK), vaginalnega obročka ali transdermalnega obliža) Najbolje je, da ženska začne z jemanjem zdravila IOA dan potem, ko je vzela zadnjo tableto z zdravilnimi učinkovinami prejšnjih KPK, vendar najpozneje na dan po običajnem premoru brez jemanja tablet oziroma po jemanju placebo tablet od prejšnjih KPK.
Stroke 
Slika
• if you have a problem with your heart (valve disorder, disturbance of the rhythm called atrial 
• če imate migrene, zlasti migrene z avro, • če imate težave s srcem (okvaro srčnih zaklopk, motnjo srčnega ritma, ki jo imenujemo atrijska fibrilacija).
If you need to stop IOA ask your doctor when you 
Če morate prenehati jemati zdravilo IOA, zdravnika vprašajte, kdaj ga lahko znova začnete uporabljati.
Eye disorders contact lens intolerance/dry eye 
• suho oko, neprenašanje kontaktnih leč
• if you need an operation or if you are off your feet for a long time (see in section 2 ‘Blood clots). 
• če potrebujete kirurški poseg ali če dolgo časa niste na nogah (glejte v poglavju 2 "Krvni strdki"); • če ste pravkar rodili, imate večje tveganje za krvne strdke.
• chest pain, discomfort, pressure, heaviness • sensation of squeezing or fullness in the chest, arm or below the 
• bolečina, nelagodje, občutek pritiska ali teže v prsnem košu;
Antithrombotic treatment should be considered if IOA has not been discontinued in advance. 
Če uporaba zdravila IOA ni predhodno prekinjena, je treba razmisliti o antitrombotičnem
Active film-coated tablets: white, round and coded ‘ne' on both sides. 
Filmsko obložene tablete z zdravilno učinkovino: bele, okrogle, z oznako "ne" na obeh straneh Filmsko obložene placebo tablete: rumene, okrogle, z oznako "p" na obeh straneh
If you start later than day 28, you should also use a barrier method of contraception during the first 7 days of IOA use. 
28. dnevu, morate prvih 7 dni jemanja zdravila IOA uporabljati še pregradno metodo kontracepcije.
Other medical conditions associated with 
Druga klinična stanja, povezana z VTE
No preceding hormonal contraceptive use (in the past month) Tablet-taking has to start on day 1 of the woman's natural cycle (i.e. the first day of her menstrual bleeding). 
Z jemanjem tablet mora ženska začeti na prvi dan svojega naravnega ciklusa (t.j.
When changing from a progestogen-only injectable, implant or a hormone-medicated intrauterine Start using IOA when your next injection is due or on the day that your implant or IUS is removed. 
Zdravilo IOA začnite uporabljati, ko bi bila na vrsti naslednja injekcija ali na dan, ko vam odstranijo vsadek ali IUS.
• Presence or risk of arterial thromboembolism (ATE) o Arterial thromboembolism - current arterial thromboembolism, history of arterial thromboembolism (e.g. myocardial infarction) or prodromal condition (e.g. angina o Cerebrovascular disease - current stroke, history of stroke or prodromal condition o Known hereditary or acquired predisposition for arterial thromboembolism, such as hyperhomocysteinaemia and antiphospholipid-antibodies (anticardiolipin-antibodies, 
• Prisotna arterijska trombembolija (ATE) ali tveganje zanjo o Arterijska trombembolija - obstoječa arterijska trombembolija, arterijska trombembolija v anamnezi (npr. miokardni infarkt) ali prodromalna stanja (npr. angina pektoris).
In case a vaginal ring or transdermal patch has been used, the woman should start using IOA preferably on the day of removal, but at the latest when the next application would have been due. 
Če je uporabljala vaginalni obroček ali transdermalni obliž, je najbolje, da z jemanjem zdravila IOA začne še isti dan, ko odstrani obroček ali obliž, vendar najpozneje na dan, ko bi morala začeti uporabljati naslednji obroček ali obliž.
o Known hereditary or acquired predisposition for venous thromboembolism, such as APCresistance (including Factor V Leiden), antithrombin-III-deficiency, protein C deficiency, 
o Znana dedna ali pridobljena nagnjenost k venski trombemboliji, kot so rezistenca na aktivirani protein C (APC; vključno s faktorjem V Leiden), pomanjkanje antitrombina-III, pomanjkanje proteina C, pomanjkanje proteina S. o Večji kirurški poseg z dolgotrajno imobilizacijo (glejte poglavje 4.4).
• if you notice possible signs of a blood clot that may mean you are suffering from a blood clot in the leg (i.e., deep vein thrombosis), a blood clot in the lung (i.e., pulmonary embolism), a heart attack or a stroke (see “Blood clots” section below). 
globoka venska tromboza), krvnega strdka v pljučih (tj. pljučna embolija), srčnega infarkta ali možganske kapi (glejte poglavje "Krvni strdki" spodaj).
IOA is unlikely to affect your ability to drive or use machines. 
Vpliv na sposobnost upravljanja vozil in strojev Malo je verjetno, da bi zdravilo IOA kakor koli vplivalo na vašo sposobnost vožnje in upravljanja strojev.
If any of these conditions appear for the first time while using IOA, stop taking it at once and tell your doctor. 
Če se med uporabo zdravila IOA prvič pojavi katera od navedenih motenj, takoj prenehajte jemati zdravilo in se posvetujte z zdravnikom, medtem pa uporabljajte nehormonske kontracepcijske metode.
• if you are to be immobilised or are to have surgery (tell your doctor at least four weeks in 
• če boste jemali druga zdravila (glejte tudi poglavje 2 "Druga zdravila in zdravilo IOA"); • če boste imobilizirani ali boste imeli operacijo (o tem morate zdravnika obvestiti najmanj štiri tedne vnaprej);
IOA will work immediately. 
IOA niso na voljo.
If you have severe diarrhoea, please tell your 
Če imate hudo drisko, se, prosimo, posvetujte z zdravnikom.
An implant or IUS may be removed any day, and IOA should be started on the day of its removal. 
Mini tabletko lahko ženska preneha jemati kateri koli dan in začne jemati zdravilo IOA naslednji dan. Vsadek ali IUS se lahko odstrani kateri koli dan in ženska začne jemati zdravilo IOA na dan njegove odstranitve.
Factors that increase your risk of a blood clot in an artery It is important to note that the risk of a heart attack or stroke from using IOA is very small but can 
Zavedati se je treba, da je tveganje za srčni infarkt ali možgansko kap zaradi uporabe zdravila IOA zelo majhno, a se lahko poveča:
• if you need an operation or if you are off your feet for a long time (see section ‘Blood clots); 
• če potrebujete kirurški poseg ali če dolgo časa niste na nogah (glejte poglavje "Krvni strdki"); • če ste kdaj imeli srčni infarkt ali možgansko kap;
If pregnancy occurs while taking IOA, further intake should be stopped. 
Če ženska zanosi v času jemanja zdravila IOA, mora takoj prenehati z njegovo uporabo.
Yellow tablets from the last (4th) row of the blister can be disregarded. 
Rumene tablete iz zadnje (4.)
Tablet core (white active and yellow placebo film-coated tablets) 
Obloga tablete (bele filmsko obložene tablete z zdravilno učinkovino)
• rapid or irregular heartbeat; 
• hitro ali neredno bitje srca.
QUALITATIVE AND QUANTITATIVE COMPOSITION White active film-coated tablets: Each film-coated tablet contains 2.5 mg nomegestrol acetate and Yellow placebo film-coated tablets: The tablet does not contain active substances. 
KAKOVOSTNA IN KOLIČINSKA SESTAVA Bele filmsko obložene tablete z zdravilno učinkovino: Ena filmsko obložena tableta vsebuje 2,5 mg nomegestrolacetata in 1,5 mg estradiola (v obliki hemihidrata).
IOA is indicated for the prevention of pregnancy. 
Zdravilo IOA je indicirano za preprečevanje zanositve.
premenstrual syndrome; pain during intercourse; dryness in the vagina or vulva; spasm of the uterus 
predmenstrualni sindrom, bulica v dojkah, disparevnija, suhost vulve in nožnice izrazit vonj iz nožnice,
• 7 days of uninterrupted ‘white active tablet'-taking are required to attain adequate suppression of the hypothalamic-pituitary-ovarian-axis. 
Za ravnanje v primeru pozabljene tablete veljata naslednji dve osnovni pravili: • za doseganje zadostne zavore hipotalamo-hipofizno-ovarijske osi je potrebnih 7 dni neprekinjenega jemanja belih tablet z zdravilno učinkovino,
The protection against pregnancy is not reduced, and you do not need to take extra precautions. 
Zaščita pred zanositvijo ni zmanjšana,
The breast cancers diagnosed in ever-users tend to be less advanced clinically than the cancers diagnosed in never-users. 
so običajno v manj napredovalem kliničnem stadiju kot pri tistih, ki jih nikoli niso uporabljale.
Therefore, a hepatic tumour should be considered in the differential diagnosis when severe upper abdominal pain, liver enlargement or signs of intra-abdominal haemorrhage occur in women taking COCs. 
Če se pri ženski, ki uporablja KPK, pojavijo hude bolečine v zgornjem delu trebuha, povečanje jeter ali znaki krvavitve v trebuhu, je treba v diferencialni diagnozi upoštevati tudi morebitne jetrne tumorje.
Poly(vinyl alcohol) (E1203), titanium dioxide (E171), macrogol 3350, talc (E553b), iron oxide yellow (E172) and iron oxide black (E172) 
polivinilalkohol (E1203) titanov dioksid (E171) makrogol 3350 smukec (E553b)
B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY 
D. POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN
Oral use. 
NAVODILA ZA UPORABO
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Marketing Authorisation Holder: 
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM
• golden brown pigment patches, mostly in the face; excessive hair growth • vaginal smell; discomfort in the vagina or vulva 
• rumeno rjave pigmentne lise, večinoma na obrazu, čezmerna poraščenost
• sharp chest pain which may increase with deep breathing; 
• nenaden kašelj, brez očitnega razloga, lahko z izkašljevanjem krvi; • ostra bolečina v prsih, ki se lahko poveča med globokim dihanjem;
• severe light headedness or dizziness; 
• skrajna šibkost, tesnoba ali kratka sapa;
• if you have any of the following diseases that may increase your risk of a clot in the arteries: - severe diabetes with blood vessel damage - very high blood pressure - a very high level of fat in the blood (cholesterol or triglycerides); - a condition known as hyperhomocysteinaemia 
hudo sladkorno bolezen s poškodovanimi krvnimi žilami zelo visok krvni tlak zelo visoko koncentracijo maščob v krvi (holesterola ali trigliceridov)
After finishing the 4 yellow placebo tablets from the second blister, 
Ko ste porabili 4 rumene placebo tablete iz drugega pretisnega omota, začnite z jemanjem tablet iz naslednjega (tretjega) pretisnega omota.
Hepatobiliary disorders cholelithiasis, cholecystitis hyperhydrosis, alopecia, pruritus, dry skin, seborrhea chloasma, hypertrichosis sensation of heaviness hypomenorrhoea, breast swelling, galactorrhoea, uterine spasm, premenstrual syndrome, breast mass, dyspareunia, vulvovaginal dryness vaginal odour, vulvovaginal discomfort irritability, oedema hunger weight increased hepatic enzyme increased 
Bolezni kože in akne hiperhidroza, alopecija, pruritus, suha koža, seboreja kloazma, hipertrihoza
However, pregnancy must be ruled out before IOA use is continued, if IOA has not been taken as directed or if two consecutive 
Če pa zdravila IOA ni jemala v skladu z navodili ali če ni imela dveh zaporednih odtegnitvenih krvavitev, je treba izključiti nosečnost, preden lahko nadaljuje z jemanjem zdravila IOA.
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTER 
neprijeten občutek v vulvi in nožnici
However, steroid hormones may be poorly metabolized in women with impaired liver function. 
Študij za oceno vpliva jetrnih bolezni na farmakokinetiko zdravila IOA niso izvedli, vendar se pri ženskah z motnjami delovanja jeter steroidni hormoni lahko slabo presnavljajo.
If your present pill blister also contains inactive (placebo) tablets you can start IOA on the day after taking the last active tablet (if you are not sure which this is, ask your doctor or pharmacist). 
Če vaš trenutni pretisni omot s tabletami vsebuje tudi neaktivne tablete (placebo), lahko z jemanjem zdravila
• swelling and slight blue discolouration of an extremity; • severe pain in your stomach (acute abdomen). 
• močna bolečina v trebuhu (akutni abdomen).
• harmful blood clots in a vein or artery, for example: o in a leg or foot (i.e., DVT) o in a lung (i.e., PE) o heart attack o stroke o mini-stroke or temporary stroke-like symptoms known as a transient ischaemic attack (TIA) o blood clots in the liver, stomach/intestine, kidneys or eye. 
o v pljučih (pljučna embolija) o srčni infarkt o možganska kap o "mala možganska kap" ali prehodni, možganski kapi podobni simptomi, znani kot prehodni ishemični napad (TIA - tranzitorna ishemična ataka).
The user is unlikely to have a withdrawal bleed until the end of the active tablets section of the second pack, but she may experience spotting or breakthrough 
Verjetno ne bo imela odtegnitvene krvavitve, dokler ne bo zaključila z jemanjem tablet z zdravilno učinkovino iz drugega pretisnega omota, lahko pa bo imela vmesne krvavitve ali krvave madeže med jemanjem tablet.
• sweating, nausea, vomiting or dizziness; • extreme weakness, anxiety, or shortness of breath; 
• znojenje, siljenje na bruhanje (navzea), bruhanje ali omotica;
When no hormonal contraceptive has been used in the past month Start taking IOA on the first day of your cycle (i.e. the first day of your menstrual bleeding). 
Zdravilo IOA začnite jemati na prvi dan ciklusa (t.j.
Method of administration 
B. NAVODILO ZA UPORABO
Diabetes mellitus, hyperhomocysteinaemia, valvular heart disease and atrial fibrillation, dyslipoproteinaemia and systemic lupus erythematosus 
bolezen srčnih zaklopk in atrijska fibrilacija,
Where considered appropriate, COC use may be resumed if normotensive values can be achieved with antihypertensive therapy. 
Ko so z antihipertenzivno terapijo dosežene normotenzivne vrednosti, lahko ženska nadaljuje z uporabo KPK, seveda če zdravnik meni, da je to ustrezno.
Contact your doctor immediately. 
Poiščite nujno medicinsko pomoč
Hepatic impairment 
Vpliv ledvične okvare
You do not need to use an additional contraceptive method. 
Lahko vas bodo namreč opozorili, da morate v tem času uporabljati dodatne kontracepcijske metode
• fullness, indigestion or choking feeling; • upper body discomfort radiating to the back, jaw, throat, arm and 
• nelagodje v zgornjem delu trupa, ki se širi v hrbet, čeljust, vrat, roko ali želodec;
Symptoms most commonly occur in one eye: • painless blurring of vision which can progress to loss of vision 
• neboleča zameglitev vida, ki lahko napreduje v izgubo vida;
They can tell you if you need to take additional contraceptive precautions (barrier method) and, if so, for how long. 
(pregradno metodo) in vam povedali, kako dolgo.
Package leaflet: Information for the user 
OZNAČEVANJE IN NAVODILO ZA UPORABO
Tablet coating (yellow placebo film-coated tablets) Poly(vinyl alcohol) (E1203) Titanium dioxide (E171) 
Obloga tablete (rumene placebo filmsko obložene tablete) polivinilalkohol (E1203) titanov dioksid (E171) makrogol 3350 smukec (E553b) rumeni železov oksid (E 172)
Day 18-24 of white active tablet intake (see picture and schedule) There is a particularly high risk of becoming pregnant if you miss white active tablets close to the yellow placebo tablet interval. 
18. do 24. dan jemanja belih aktivnih tablet (glejte sliko in shemo)
The risk of arterial thromboembolic complications or of a cerebrovascular accident in CHC users increases in women with risk factors (see table). 
Dejavniki tveganja za ATE Tveganje za arterijske trombembolične zaplete ali cerebrovaskularni dogodek je med uporabnicami
Starting your first pack of IOA 
Če začnete z jemanjem po